{"schema_version":"secwatch.filing_event.v1","accession":"0000785161-26-000156","form_type":"8-K","ticker":"EHC","cik":"0000785161","company_name":"Encompass Health Corp","filed_at":"2026-05-15T19:24:47+00:00","discovered_at":"2026-05-15T19:26:00.369680+00:00","generated_at":"2026-05-15T19:26:08.477442+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.52,"calibrated_materiality_score":0.52,"confidence":"high","headline":"Encompass Health prices $500M of 5.875% senior notes due 2034 to refinance debt","bullets":["Issued $500M aggregate principal of 5.875% senior notes due 2034; closing expected May 29, 2026.","Net proceeds plus cash to redeem $400M of 4.500% senior notes due 2028 at par.","Also will repay $100M outstanding under its revolving credit facility.","Wells Fargo Securities acted as representative of the initial purchasers."],"urls":{"canonical":"https://secwatch.observer/filing/0000785161-26-000156","json":"https://secwatch.observer/filing/0000785161-26-000156.json","markdown":"https://secwatch.observer/filing/0000785161-26-000156.md","text":"https://secwatch.observer/filing/0000785161-26-000156.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000156/0000785161-26-000156-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000156/ehc-20260514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T19:26:08.477442+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bf0c0a30d980bd612c3d85f196f4c93ce19fa16c","claim":"Encompass Health Corp entered into Purchase Agreement with Wells Fargo Securities, LLC, as the representative of the initial purchasers valued at $500,000,000 in aggregate principal amount of 5.875% senior notes due 2034 (effective 2026-05-14).","evidence_excerpt":"On May 14, 2026, Encompass Health Corporation (the “Company”) and certain of its subsidiaries, as guarantors (the “Guarantors”), entered into a purchase agreement (the “Purchase Agreement”) with Wells Fargo Securities, LLC, as the representative of the initial purchasers (the “Initial Purchasers”), with respect to a private offering (the “Notes Offering”) by the Company of $500,000,000 in aggregate principal amount of 5.875% senior notes due 2034 (the “Notes”), along with the related guarantees of the Notes.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000156/0000785161-26-000156-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Wells Fargo Securities, LLC, as the representative of the initial purchasers"},{"label":"Value","value":"$500,000,000 in aggregate principal amount of 5.875% senior notes due 2034"},{"label":"Effective","value":"2026-05-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}